Supplements

Glucocorticoid exposure is associated with poorer sleep continuity and reduced deep sleep in patients with rheumatoid arthritis

In a pilot study of 20 RA patients, glucocorticoid users had significantly longer wake after sleep onset (WASO), shorter NREM stage N3 duration, and lower delta power compared to non-users, despite comparable disease activity. These findings suggest that GC exposure may impair sleep architecture independent of RA disease activity.

Last updated: Aug 28, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score34/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Association Between Glucocorticoid Exposure and Objective Sleep Architecture in Rheumatoid Arthritis: An Exploratory Pilot EEG Study.

observational

Yamada S, Hayashi N, Fujita Y, Katsusima M, Fukumoto K, Watanabe R, Hashimoto M · Journal of clinical medicine (2026)

Participants: N/A
Duration: Not specified (cross-sectional)
Intervention: Glucocorticoid exposure (users vs. non-users)
Outcome: Objective sleep architecture: WASO, NREM stage N3 duration, delta power, sleep efficiency, heart rate variability (LF/HF ratio)
Effect Size: N/A (Spearman correlations reported but exact coefficients not provided in abstract)
Population: Patients with rheumatoid arthritis (mean age 64.9 years, 9 GC users, 11 non-users)

Result:

PubMed: 42652735DOI: 10.3390/jcm15166331

Mechanism Graph

Glucocorticoids activate glucocorticoid receptors in the brain
↓
This may alter hypothalamic-pituitary-adrenal axis feedback and neurotransmitter systems
↓
Disruption of sleep-wake regulation leads to increased wakefulness and reduced slow-wave sleep
↓
Result: longer WASO, shorter N3 duration, lower delta power

Limitations

  • ⚠Small sample size (n=20) and single-center exploratory design
  • ⚠Cross-sectional design prevents causal inference
  • ⚠Potential confounding by indication (GC use may reflect more severe disease despite similar DAS28-CRP)

Frequently Asked Questions

Does glucocorticoid use affect sleep quality in rheumatoid arthritis patients?▼

Yes, this study found that GC users had significantly longer wake after sleep onset and reduced deep sleep (NREM stage N3 and delta power) compared to non-users, even when disease activity was similar.

What sleep parameters were measured in this study?▼

Sleep parameters included wake after sleep onset (WASO), sleep stages (including NREM stage N3), delta EEG power during the first sleep cycle, total sleep time, sleep latency, and sleep efficiency. Heart rate variability (LF/HF ratio) was also assessed.

Was disease activity different between glucocorticoid users and non-users?▼

No, disease activity as measured by DAS28-CRP was not significantly different between the two groups, suggesting that the sleep differences were associated with glucocorticoid exposure rather than disease severity.

Are these findings definitive?▼

No, this is an exploratory pilot study with a small sample size. The authors caution that findings should be interpreted cautiously and larger longitudinal studies are needed to confirm the associations.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Yamada S, Hayashi N, Fujita Y, Katsusima M, Fukumoto K, Watanabe R, Hashimoto M. "Association Between Glucocorticoid Exposure and Objective Sleep Architecture in Rheumatoid Arthritis: An Exploratory Pilot EEG Study.." Journal of clinical medicine, 2026. PMID: 42652735 DOI: 10.3390/jcm15166331
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.